WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has kicked off c...
South Korea-based Samsung Bioepis Co. has entered into a license, development and commercialisation agreement with Nipro...
Iceland-based Alvotech, a global biotech company specialising in the development and manufacture of biosimilar medicines...
Australia-headquartered Telix Pharmaceuticals has established Telix Manufacturing Solutions (TMS) in Yokohama, Japan. Te...
Eisai Co. has announced the launch of Pariet® S”(pharmaceutical requiring guidance), which is highly effective...
French pharmaceutical company Sanofi and Blueprint Medicines Corporation, a US-based, publicly traded biopharmaceutical ...
Article by Hithaishi Bhaksar Singapore is stepping up its efforts to manage hazardous waste sustainably, aligning with ...
Asia-Pacific is emerging as a major centre for Global Capability Centres for the Life Sciences and Healthcare industry i...
What are the major plans in store after this acquisition? Is there a phase-wise plan? Following the acquisition, Syngen...
The biopharma job market has been tough, with widespread downsizing and frequent layoffs across big pharma. But the wors...
Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has announced the Australian registration of SKY...
CPHI & PMEC China (June 24-26th) returns to the Shanghai New International Expo Center amid a marked surge in i...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Adalvo Limited in the Europe...
Taxis Pharmaceuticals, a US-based clinical stage company at the forefront of developing therapies to treat multidrug-res...
US-based BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, has a...
Shanghai Pharmaceutical Group and Novartis, a global pharmaceutical giant, have officially signed a strategic cooperatio...
Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro (tirzepatide), the inno...
The 92nd edition of API China successfully wrapped up on 23 May, reaffirming its role as a cornerstone ev...
It was a privilege to share BioSpectrum Asia’s vision and editorial focus with AVING News during ICPI Week 2025 in...
ICPI Week 2025 Wrap-Up ICPI WEEK 2025 WRAP-UP | BY MANBEENA CHAWLA, EXECUTIVE EDITOR, BIOSPECTRUM ASIA ...
Eli Lilly and Company has announced that the Australian Therapeutic Goods Administration (TGA) has granted marketing aut...
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced th...
The BioMed X Institute has announced the launch of a new global call for research proposals in collaborat...
Pfizer Inc. has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc., a leading Chinese biop...
CanSino Biologics Inc, based in China, has obtained clinical trial approval from the Badan Pengawas Obat danMakanan, Rep...
